The effect of oral trypsin inhibitor on pancreatic damage in the rat.
D000284:Administration, Oral; D000626:Aminopeptidases / Q000494:pharmacology; D000681:Amylases / Q000032:analysis; D000818:Animals; D001652:Bile Ducts; D002467:Cell Nucleus; D005001:Ethionine / Q000494:pharmacology; D007930:Leucine / Q000494:pharmacology; D008297:Male; D008938:Mitosis; D009281:Naphthalenes / Q000494:pharmacology; D009336:Necrosis / Q000139:chemically induced; D009929:Organ Size; D010179:Pancreas / Q000201:enzymology / Q000473:pathology; D010182:Pancreatic Diseases / Q000188:drug therapy*; D010183:Pancreatic Ducts; D010195:Pancreatitis / Q000517:prevention & control; D011506:Proteins / Q000032:analysis; D051381:Rats; D014361:Trypsin Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
D009281:Naphthalenes; D011506:Proteins; D014361:Trypsin Inhibitors; D000681:Amylases; D000626:Aminopeptidases; D007930:Leucine; D005001:Ethionine